Data / Drug companies / Typical Antipsychotic
Typical Antipsychotic drugs: 6 drugs from 52 companies in the FDA NDC directory
Typical Antipsychotic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 253 products in this class from 52 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 14, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 52Companies
- 253Products
- 6Drugs by generic name
Drugs in the Typical Antipsychotic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Haloperidol | 165 | 32 |
| Haloperidol decanoate | 58 | 16 |
| Haloperidol lactate | 10 | 6 |
| Thiothixene | 13 | 4 |
| Pimozide | 4 | 2 |
| Molindone hydrochloride | 3 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 18 | tablet; injection | Generic drugs (ANDA) | August 12, 2026 |
| Bryant Ranch Prepack | 12 | tablet | Generic drugs (ANDA) | January 5, 2026 |
| Method Pharmaceuticals, LLC | 12 | tablet | Generic drugs (ANDA) | June 5, 2025 |
| Coupler LLC | 11 | tablet; capsule | Generic drugs (ANDA) | August 3, 2026 |
| Lifestar Pharma LLC | 10 | tablet; injection | Generic drugs (ANDA) | April 11, 2024 |
| Somerset Therapeutics, LLC | 9 | injection | Generic drugs (ANDA) | September 29, 2025 |
| BluePoint Laboratories | 8 | injection | Generic drugs (ANDA) | June 12, 2025 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | November 25, 2019 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | April 19, 2024 |
| AiPing Pharmaceutical, Inc. | 6 | tablet | Generic drugs (ANDA) | April 8, 2026 |
| Ajanta Pharma USA Inc. | 6 | tablet | Generic drugs (ANDA) | September 14, 2026 |
| Amici Pharma, Inc. | 6 | tablet | Generic drugs (ANDA) | April 18, 2022 |
| Ani Pharmaceuticals, Inc. | 6 | capsule; tablet | Generic drugs (ANDA) | April 21, 2026 |
| Aurobindo Pharma Limited | 6 | tablet | Generic drugs (ANDA) | April 19, 2024 |
| Creekwood Pharmaceuticals LLC | 6 | tablet | Generic drugs (ANDA) | January 5, 2026 |
| Innogenix, Inc. | 6 | tablet | Generic drugs (ANDA) | February 18, 2021 |
| Marlex Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | August 1, 2022 |
| Novadoz Pharmaceuticals LLC | 6 | tablet | Generic drugs (ANDA) | November 18, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | April 8, 2026 |
| Upsher-Smith Laboratories, LLC | 6 | tablet | Generic drugs (ANDA) | January 9, 2020 |
| Zydus Lifesciences Limited | 6 | tablet | Generic drugs (ANDA) | February 1, 2023 |
| Zydus Pharmaceuticals USA Inc. | 6 | tablet | Generic drugs (ANDA) | February 1, 2023 |
| Hikma Pharmaceuticals USA Inc. | 5 | injection | Generic drugs (ANDA) | September 14, 2018 |
| Amneal Pharmaceuticals NY LLC | 4 | capsule | Generic drugs (ANDA) | March 3, 2022 |
| Cardinal Health 107, LLC | 4 | injection, solution; tablet | Generic drugs (ANDA) | May 10, 2011 |
| Fresenius Kabi USA, LLC | 4 | injection; injection, solution | Generic drugs (ANDA) | October 20, 2000 |
| Golden State Medical Supply, Inc. | 4 | capsule | Generic drugs (ANDA) | April 5, 2019 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | January 28, 2025 |
| Mylan Institutional Inc. | 4 | tablet | Generic drugs (ANDA) | February 15, 2004 |
| Mylan Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | June 10, 1986 |
| Zydus Lifesciences Limited | 4 | injection | Generic drugs (ANDA) | November 14, 2019 |
| Zydus Pharmaceuticals USA Inc. | 4 | injection | Generic drugs (ANDA) | November 14, 2019 |
| Armas Pharmaceuticals Inc. | 3 | injection | Generic drugs (ANDA) | May 15, 2026 |
| Caplin Steriles Limited | 3 | injection | Generic drugs (ANDA) | May 26, 2025 |
| Epic Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | October 17, 2018 |
| Meitheal Pharmaceuticals Inc. | 3 | injection | Generic drugs (ANDA) | July 26, 2021 |
| Mylan Institutional LLC | 3 | injection; injection, solution | Generic drugs (ANDA) | December 18, 2014 |
| Safecor Health, LLC | 3 | tablet | Generic drugs (ANDA) | June 1, 2026 |
| Sagent Pharmaceuticals | 3 | injection, solution | Generic drugs (ANDA) | November 15, 2017 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | April 4, 2008 |
| American Health Packaging | 2 | tablet; solution | Generic drugs (ANDA) | April 15, 2024 |
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | January 16, 2017 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | April 11, 2024 |
| Par Health USA, LLC | 2 | tablet | Generic drugs (ANDA) | September 28, 2015 |
| Patriot Pharmaceuticals | 2 | injection | Authorized generics (NDA) | June 17, 2011 |
| Advagen Pharma Ltd | 1 | solution, concentrate | Generic drugs (ANDA) | January 31, 2024 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | Generic drugs (ANDA) | March 29, 2021 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | January 11, 2022 |
| Lannett Company, Inc. | 1 | solution | Generic drugs (ANDA) | September 28, 1993 |
| NorthStar RxLLC | 1 | injection | Generic drugs (ANDA) | December 1, 2023 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | solution | Generic drugs (ANDA) | November 10, 2009 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 23, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 167 | 66% |
| Injection | 57 | 22.5% |
| Capsule | 13 | 5.1% |
| Injection, solution | 12 | 4.7% |
| Solution | 3 | 1.2% |
| Solution, concentrate | 1 | 0.4% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.